Related Experiment Video
Updated: Apr 24, 2026

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
Published on: October 27, 2023
Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis
Ilaria Cavazzana1, Mara Taraborelli, Micaela Fredi
1Rheumatology and Clinical Immunology Unit, Spedali Civili di Brescia, Brescia, Italy. ilariacava@virgilio.it.
Objectives:
Aseptic meningitis is a rare and aggressive complication of rheumatoid arthritis (RA), usually histologically characterised by rheumatoid nodules and lymphocytic aggregates in leptomeninges. The aim of this study was to describe the clinical onset and evolution of aseptic meningitis occurring during anti-TNF-alpha (TNF-α) therapy.
Methods:
we retrospectively analysed the clinical records of patients with RA or ankylosing apondylitis (AS) treated by TNF-α drugs in the last 10 years.
Results:
Four out of 718 patients, treated with TNF-α, developed meningitis after a mean of 5 years (SD: 3.7) of TNF-α exposure (0.55%). Three subjects were affected by long-standing RA (median: 11 years, IQR:8.5-25), one patient by active AS of 8 years' duration. RA patients were treated with etanercept (2 cases) and infliximab (1 case), in association with methotrexate and prednisone. The AS patient was treated with adalimumab. Neurological onset was focal epilepsy (3 cases) and dysarthria (1 case). RM showed leptomeningeal enhancement of basal nuclei (1 case) or fronto-parietal zone (3 cases), associated in one patient with cerebritis. Bacterial, viral or parasitic infections were excluded. One patient underwent cerebral biopsy showing T and B lymphocytes' aggregates. All patients discontinued TNF-α drugs and were treated with high dose of steroids, added to methotrexate in two cases. Neurological symptoms resolved without residuals, and meningeal enhancement showed resolution with high latency.
Conclusions:
Meningeal inflammation is a rare manifestation occurring in long-standing RA and AS in clinical remission. TNF-α therapy did not prevent this extra-articular complication.
Insights
Aseptic meningitis is a rare complication in rheumatoid arthritis (RA) and ankylosing spondylitis (AS) patients on anti-tumor necrosis factor-alpha (TNF-α) therapy. Discontinuation of TNF-α and steroid treatment led to symptom resolution.
Area of Science:
- Rheumatology
- Neurology
- Immunology
Background:
- Aseptic meningitis is a rare but severe complication of rheumatoid arthritis (RA).
- Tumor necrosis factor-alpha (TNF-α) inhibitors are commonly used to treat RA and ankylosing spondylitis (AS).
- The occurrence of aseptic meningitis during anti-TNF-α therapy requires further investigation.
Observation:
- Four patients (0.55%) developed meningitis after a mean of 5 years of anti-TNF-α therapy.
- Neurological symptoms included focal epilepsy and dysarthria.
- Cerebral imaging revealed leptomeningeal enhancement and, in one case, cerebritis.
Findings:
- Cerebral biopsy confirmed lymphocytic aggregates, excluding infectious causes.
- All patients discontinued anti-TNF-α therapy and received high-dose steroids, with two also receiving methotrexate.
- Neurological symptoms resolved without residuals, and meningeal enhancement showed late resolution.
Implications:
- Meningeal inflammation is a rare extra-articular manifestation in long-standing RA and AS, even during anti-TNF-α therapy.
- Anti-TNF-α therapy does not prevent this complication.
- Early diagnosis and management involving drug cessation and immunosuppression are crucial for favorable outcomes.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Acute Pyelonephritis II: Diagnostic Studies and Management
Rheumatic Heart Disease I: Introduction
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
